Amarin Corp Plcuk (AMRN) EBT (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly EBT of -$7.9 million for Q2 2026, up 41.49% year-over-year from -$5.6 million in Q2 2025, and up 9.79% quarter-over-quarter from -$8.7 million in Q1 2026.
Amarin Corp Plcuk (AMRN) EBT (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported EBT for 17 consecutive years, with -$7.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT rose 41.49% year-over-year to -$7.9 million; the TTM figure through Jun 2026 stood at -$25.6 million (up 74.06% YoY), while the FY2025 annual figure was -$36.0 million, up 53.31% from the prior year.
- EBT rose to -$7.9 million in Q2 2026 per AMRN's latest filing, from -$8.7 million in the prior quarter.
- Across five years, EBT topped out at $2.9 million in Q2 2024 and bottomed at -$64.8 million in Q2 2022.
- Historically, EBT has averaged -$16.0 million across 5 years, with a median of -$11.1 million in 2025.
- Annual changes were most pronounced in 2022 — EBT plunged 2729.34% — and 2024, when it jumped 116.14%.
- Amarin Corp Plc\Uk's EBT stood at -$6.8 million in 2022, then surged by 63.84% to -$2.4 million in 2023, then tumbled by 1937.85% to -$49.9 million in 2024, then surged by 98.29% to -$852000.0 in 2025, then plunged by 823.59% to -$7.9 million in 2026.
- Business Quant data shows AMRN's EBT at -$7.9 million in Q2 2026, -$8.7 million in Q1 2026, and -$852000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn | -7.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.87 Mn |
| Mar 31, 2026 | -8.72 Mn |
| Dec 31, 2025 | -852,000.00 |
| Sep 30, 2025 | -8.12 Mn |
| Jun 30, 2025 | -13.45 Mn |
| Mar 31, 2025 | -13.63 Mn |
| Dec 31, 2024 | -49.91 Mn |
| Sep 30, 2024 | -21.53 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | -8.66 Mn |
| Dec 31, 2023 | -2.45 Mn |
| Sep 30, 2023 | -18.81 Mn |
| Jun 30, 2023 | -17.92 Mn |
| Mar 31, 2023 | -14.50 Mn |
| Dec 31, 2022 | -6.77 Mn |
| Sep 30, 2022 | -3.88 Mn |
| Jun 30, 2022 | -64.80 Mn |
| Mar 31, 2022 | -28.35 Mn |
| Dec 31, 2021 | 16.39 Mn |
| Sep 30, 2021 | -12.97 Mn |